TipRanks
Advertisement
Advertisement

DE:722 Stock Latest News

Antengene Grants 11.52 Million RSUs Under 2022 Incentive Scheme
Company AnnouncementsAntengene Grants 11.52 Million RSUs Under 2022 Incentive Scheme
26d ago
Antengene Wins Australian Approval to Begin Phase I Trial of Autoimmune Drug ATG-201
PremiumCompany Announcements
Antengene Wins Australian Approval to Begin Phase I Trial of Autoimmune Drug ATG-201
1M ago
Antengene Swings to Interim Profit on Licensing-Driven Revenue Surge
PremiumCompany Announcements
Antengene Swings to Interim Profit on Licensing-Driven Revenue Surge
2M ago
Antengene Sets Board Meeting to Approve 2026 Interim Results
PremiumCompany Announcements
Antengene Sets Board Meeting to Approve 2026 Interim Results
2M ago
Antengene Updates Board Composition and Committee Roles
PremiumCompany Announcements
Antengene Updates Board Composition and Committee Roles
2M ago
Antengene Reshapes Leadership Team With CFO Exit and New Executive Appointments
PremiumCompany AnnouncementsAntengene Reshapes Leadership Team With CFO Exit and New Executive Appointments
2M ago
Antengene Signals Major Interim Profit on Oncology Licensing Deals
Premium
Company Announcements
Antengene Signals Major Interim Profit on Oncology Licensing Deals
2M ago
Antengene Secures USD60 Million Upfront from UCB for ATG-201 License
Premium
Company Announcements
Antengene Secures USD60 Million Upfront from UCB for ATG-201 License
3M ago
Antengene Launches HK$50 Million Share Buyback Plan
PremiumCompany Announcements
Antengene Launches HK$50 Million Share Buyback Plan
3M ago
Antengene Out-Licenses ATG-106 to K2 Therapeutics in Potential US$1.9 Billion TCE Deal
PremiumCompany Announcements
Antengene Out-Licenses ATG-106 to K2 Therapeutics in Potential US$1.9 Billion TCE Deal
4M ago
Antengene Reshuffles Joint Company Secretaries to Strengthen Governance Compliance
PremiumCompany Announcements
Antengene Reshuffles Joint Company Secretaries to Strengthen Governance Compliance
4M ago
Antengene Shareholders Back All AGM Resolutions, Bolstering Capital Flexibility
PremiumCompany Announcements
Antengene Shareholders Back All AGM Resolutions, Bolstering Capital Flexibility
4M ago
Antengene Wins China IND Nod for ATG-201 Autoimmune Trial
PremiumCompany AnnouncementsAntengene Wins China IND Nod for ATG-201 Autoimmune Trial
4M ago
Antengene Wins China IND Nod for Pivotal Phase III Trial of ATG-022 in Advanced Gastric Cancer
Premium
Company Announcements
Antengene Wins China IND Nod for Pivotal Phase III Trial of ATG-022 in Advanced Gastric Cancer
4M ago
Antengene Names New Chief Scientific Officer to Drive Next-Generation R&D Pipeline
Premium
Company Announcements
Antengene Names New Chief Scientific Officer to Drive Next-Generation R&D Pipeline
5M ago
Antengene Moves to Modernize Governance as Global Oncology Portfolio Expands
PremiumCompany Announcements
Antengene Moves to Modernize Governance as Global Oncology Portfolio Expands
5M ago
Antengene Sets 2026 AGM to Renew Governance Mandates and Share Issuance Authority
PremiumCompany Announcements
Antengene Sets 2026 AGM to Renew Governance Mandates and Share Issuance Authority
5M ago
Antengene Grants 1.9 Million Share Options and RSUs to Reward Key Talent
PremiumCompany Announcements
Antengene Grants 1.9 Million Share Options and RSUs to Reward Key Talent
6M ago
Antengene Executives Boost Stakes in Vote of Confidence on Long-Term Growth
PremiumCompany Announcements
Antengene Executives Boost Stakes in Vote of Confidence on Long-Term Growth
7M ago
Antengene Narrows Losses on Cost Cuts as Revenue Climbs in 2025
PremiumCompany AnnouncementsAntengene Narrows Losses on Cost Cuts as Revenue Climbs in 2025
7M ago
Antengene Schedules Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Antengene Schedules Board Meeting to Approve 2025 Annual Results
7M ago
Antengene Grants UCB Global Rights to ATG-201 in Autoimmune Disease Deal Worth Up to USD1.2 Billion
Premium
Company Announcements
Antengene Grants UCB Global Rights to ATG-201 in Autoimmune Disease Deal Worth Up to USD1.2 Billion
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >